I know times are tough. But I am sure that if you are reading this you can afford a tenner or a fiver. And I ask that you hand that over to the amazing folks at Woodlarks as it does its first face to face Santa grottos for 200 kids whose, often short, lives are not like those we enjoy.
Regenerative medical device company Tissue Regenix (TRX) states “following the successful launch of VNEW with ARMS Medical in September 2021, we are very pleased to be continuing our partnership and launching the VNEW Fascia Lata allograft for surgical procedures to support tissue”. So what of a share price response slightly lower to 0.575p?
It is day one of the harvest and feeling rather wet and very tired I explain a bit of what has gone on. Then it is onto Versarien (VRS), Chill Brands (CHLL) and musicMagpie (MMAG) two of which I expect to go bust in 2023.
‘Occasion wear and dressy casual wear’ fashion company Quiz plc (QUIZ) has announced results for its half-year ended 30th September 2022, arguing its performance “reflecting the appeal of our differentiated and value brand”. So what of a currently edged up to 17p share price, above £21 million market cap?
A “Contract Cancellation” announcement from Carclo (CAR), which includes that the contract was “expected to deliver incremental sales of between £10m and £15m annually for the life of the contract with the board's most recent expectation being that production volumes would start building from the last quarter of the current financial year”. So what of a current share price response down approaching 9% at 13p, a £9.5 million market cap?
The year end accounts for Zamaz (ZAMZ) are now available so I have taken a look at the more detailed information and it just highlights just what a poor-quality business Zamaz is. I have grouped the findings under a number of themes.
Medical analytics company IXICO plc (IXI) has announced what it emphasises as “a strong set of financial results… strong balance sheet supports the execution of our renewed five-year strategic plan”. So what of a share price response currently approaching 6% lower at 27.5p, to give a £13.2 million market cap?
Before we get onto the continuing comedy at Moonpig (MOON), some good news out today for GSK (GSK) and Haleon (HLN) shareholders with some observations about the Zantac (ranitidine) litigation which has hassled both the latter two shares over the last few months.
Hello Share Fans. Over the years the big tool-renter Ashtead Group (AHT) has been a big money spinner for me. Though a few years ago, I took the view that what goes up usually always comes down. So I sold the lot. Needless to say, that folly sparked yet another rally. I’m still shy of the shares, though. For the same reason: that good things don’t last forever. However, the firm’s latest numbers look to prove me wrong yet again.